ABSTRACT Transient receptor potential melastatin 3 (TRPM3) is a calciumpermeable nonselective cation channel that is expressed in a subset of dorsal root (DRG) and trigeminal ganglia sensory neurons. TRPM3 can be activated by the neurosteroid pregnenolone sulfate (PregS) and heat. TRPM3 2/2 mice display an impaired sensation of noxious heat and thermal hyperalgesia. We have previously shown that TRPM3 is blocked by the citrus fruit flavanones hesperetin, naringenin, and eriodictyol as well as by ononetin, a deoxybenzoin from Ononis spinosa. To further improve the tolerability, potency, and selectivity of TRPM3 blockers, we conducted a hit optimization procedure by rescreening a focused library that was composed of chemically related compounds. Within newly identified TRPM3 blockers, isosakuranetin and liquiritigenin displayed favorable properties with respect to their inhibitory potency and a selective mode of action. Isosakuranetin, a flavanone whose glycoside is contained in blood oranges and grapefruits, displayed an IC 50 of 50 nM and is to our knowledge the most potent inhibitor of TRPM3 identified so far. Both compounds exhibited a marked specificity for TRPM3 compared with other sensory TRP channels, and blocked PregS-induced intracellular free Ca 21 concentration signals and ionic currents in freshly isolated DRG neurons. Furthermore, isosakuranetin and previously identified hesperetin significantly reduced the sensitivity of mice to noxious heat and PregS-induced chemical pain. Because the physiologic functions of TRPM3 channels are still poorly defined, the development and validation of potent and selective blockers is expected to contribute to clarifying the role of TRPM3 in vivo.
Introduction
Transient receptor potential melastatin 3 (TRPM3) is a member of the large superfamily of TRP ion channels. The TRPM3 gene encodes a number of different alternative splice variants (Lee et al., 2003; Oberwinkler et al., 2005; Frühwald et al., 2012) . Alternative splicing within exon 24 affects the putative pore region, resulting in distinct biophysical properties of the permeation pathway. The TRPM3a1 variant is predominantly selective for monovalent cations whereas TRPM3a2, a 12-amino-acid shorter variant, forms a calciumpermeable poorly selective cation channel (Oberwinkler et al., 2005) .
TRPM3a2 channels can be activated by the neurosteroid pregnenolone sulfate (PregS), nifedipine (Wagner et al., 2008) , D-erythro-sphingosine (Grimm et al., 2005) , and by noxious heat (Vriens et al., 2011) . TRPM3 is functionally expressed in insulin-secreting pancreatic beta cells, and its activation has been linked to insulin secretion (Wagner et al., 2008) . Furthermore, TRPM3a2 is expressed in neurons of dorsal root ganglia (DRG) and trigeminal ganglia, where it contributes to the detection of noxious heat in healthy and inflamed tissue (Vriens et al., 2011) . Activation of TRPM3 has also been coupled to vascular smooth muscle cell contraction (Naylor et al., 2010) , to oligodendrocyte differentiation, and to neuronal myelination (Hoffmann et al., 2010) .
Recently, we showed that TRPM3 is blocked by citrus fruit flavanones and fabacea secondary metabolites (Straub et al., 2013) . Flavanones, a subgroup of flavonoids, comprise the most common group of plant-derived polyphenolic compounds in the human diet (Manach et al., 2004) . Flavonoids share a common structure: they consist of two aromatic rings (A and B rings) that are linked with a heterocycle (C ring) (Fig. 1A) . They can be divided into different subgroups, depending on the oxidation of the C ring, the hydroxylation pattern of the phenolic rings, and the substitution at the 3-position.
For a better understanding of the biologically active flavonoid substructure that bears responsibility for TRPM3 block, we performed a rescreening of a focused library that was composed of members of different flavonoid subgroups and of flavanones with different substitutions on specified positions. Within the flavonoids, only substances that comprise a flavanone backbone displayed a biologic activity to block TRPM3. Within the flavanones, we identified isosakuranetin and liquiritigenin as novel potent and specific TRPM3 blockers. The novel identified compounds blocked endogenously expressed TRPM3 in freshly isolated DRG neurons. Furthermore, we demonstrate that isosakuranetin and the previously identified hesperetin block TRPM3-related nociception in vivo.
Materials and Methods
Cell Culture. Human embryonic kidney 293 (HEK293) cells used for transient transfection were cultured in Earle's minimum essential medium (Invitrogen/Life Technologies, Carlsbad, CA), supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 units×ml 21 penicillin, and 0.1 mg×ml 21 streptomycin. HEK293 cells stably expressing myc-tagged mouse TRPM3a2 (HEK mTRPM3 ) were obtained and maintained as described elsewhere (Frühwald et al., 2012; Straub et al., 2013) . HEK293 cells stably expressing other sensory transient receptor potential (TRP) channels (HEK hTRPA1 , HEK hTRPM8:CFP , HEK rTRPV1:YFP ) were obtained by a limiting dilution method, as described recently elsewhere (Hellwig et al., 2004; Urban et al., 2012) . Stably transfected cell lines were selected and maintained in HEK293 medium, containing 400 mg×ml 21 G418 (geneticin). All cells were grown at 37°C in a humidified atmosphere containing 5% CO 2 . Unless otherwise stated, cells were seeded 24 hours before the experiments onto poly-L-lysine-coated coverslips.
Cell Transfection. HEK293 cells were transiently transfected with a bicistronic expression plasmid, encoding Myc-tagged TRPM1 and enhanced green fluorescent protein, as previously described elsewhere (Lambert et al., 2011; Straub et al., 2013) . For heat activation of TRPM3, HEK293 cells were transiently transfected with a bicistronic plasmid encoding TRPM3a2 and a green fluorescent protein protein. For detailed information, see Straub et al. (2013) .
DRG Neuron Preparation. Eight-week-old male and female Wistar rats were sacrificed by an overdose of CO 2 . To expose the spinal cord, a careful single dorsal-midline incision along the entire length of the body was made. The spinal cord was then gently removed, and dorsal root ganglia from all cervical, thoracic, and lumbar segments were obtained. Ganglia were digested for 35 minutes at 37°C in an enzyme solution containing 1. ; SigmaAldrich), placed in a culture dish, and left to adhere for at least 1 hour in an incubator (37°C, 5% CO 2 ). Afterward, the culture dish was then filled with DMEM. All experiments were performed within 36 hours after preparation.
Intracellular Ca 21 Analysis in Cell Suspensions. All fluorometric assays in cell suspensions were performed in 384-well plates. For detailed information, see Nörenberg et al. (2012) and Straub et al. (2013) . Shortly, HEK293 cells stably expressing TRPM3 were incubated with a fluorescent indicator dye Fluo-4/AM (4 mM; Molecular Probes/Life Technologies, Eugene, OR) for 30 minutes at 37°C, washed, and resuspended in HEPES-buffered solution, containing 135 mM NaCl, 6 mM KCl, 1 mM CaCl 2, 1 mM MgCl 2 , 5.5 mM D-glucose, and 10 mM HEPES adjusted to pH 7.4 with NaOH. Fluorescence was monitored with a filter-based plate reader device (Polastar Omega; BMG Labtech, Offenburg, Germany) in the bottom-read mode, applying 485\10-nm and 520\20-nm bandpass filters for excitation and emission, respectively. Measurements of agonistic properties of the compounds were performed using a custom-made fluorescence plate imaging device built into a robotic liquid handling station (Freedom EVO 150; Tecan Group, Männedorf, Switzerland), as recently described elsewhere (Nörenberg et al., 2012) . To correct for unequal loading and detection sensitivity, fluorescence intensities F measured in single wells were normalized to the respective initial intensities F 0 and depicted as timelapse analyses (F/F 0 ).
Single-Cell Calcium Measurement. Single-cell measurement of [Ca 21 ] i in rat DRG neurons and in transiently transfected HEK293 cells was performed as previously described elsewhere (Straub et al., 2013) . Fluorescence of the ratiometric indicator dye Fluo-2 was alternately assessed at excitation wavelengths of 340 and 380 nm. The ratio of the respective background-corrected fluorescence intensities (F 340 /F 380 ) was calculated and depicted. All measurements were performed at room temperature (22-24°C).
Whole-Cell Patch-Clamp Measurements. All electrophysiologic measurements were performed in the whole-cell voltage-clamp mode at room temperature, using an Axopatch 200B amplifier, connected to a desktop computer via a Digidata 1200 digitizer (Axon CNS; Molecular Devices, Sunnyvale, CA) under the control of the Pclamp 9 or Pclamp 10 software (Molecular Devices). To obtain current-voltage (I-V) curves, V h was set to 2113 mV for 100 milliseconds, and voltage ramps from 2113 to 1 87 mV (0.4 mV×ms 21 ) were applied once per second. The intersweep holding potential was 213 mV. Concentration response curves were obtained with a voltage step protocol by repeatedly applying a V clamp of 2113 mV and 187 mV (duration of 50 milliseconds each) every 200 milliseconds. TRPM3 currents typically reached a steady state within less than 15 milliseconds and were averaged over a time window of 20-50 milliseconds after applying voltage steps. The intracellular solution contained 80 mM Cs-aspartate, 45 mM CsCl, 4 mM Na 2 ATP, 10 mM HEPES, 10 mM BAPTA [(1,2-bis(o-aminophenoxy) ethane-N,N,N9, N9-tetraacetic acid], 5 mM EGTA pH 7.2 adjusted with CsOH. The osmolarity was 300-315 mOsm. The extracellular solution used contained 145 mM NaCl, 3 mM KCl, 10 mM CsCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM HEPES, 10 mM D-glucose, pH 7.4 adjusted with NaOH. The Cs 1 -based, divalent-free external solution for TRPM7 measurements contained 130 mM CsCl, 50 mM mannitol, 10 mM HEPES, pH 7.4 with CsOH. The liquid junction potential between the bath and the pipette solutions was 13 mV (calculated with Clampex; Axon Instruments/Molecular Devices) and corrected. Series resistances were ,10 MV and were compensated by 75-85%. The sampling rate was 5 kHz in standard whole cell measurements. For whole-cell measurements in DRG neurons, the extracellular solution contained 140 mM NaCl, 4 mM KCl, 2 mM MgCl 2 , 100 nM tetrodotoxin, 10 mM tris(hydroxymethyl)aminoethane (TRIS; pH 7.4 with HCl), and the pipette solution contained 140 mM CsCl, 0.6 mM MgCl 2 , 1 mM EGTA, 10 mM HEPES, 5 mM TEA (pH 7.2 with CsOH).
To determine the I-V relationship of PregS-induced currents, measurements were performed under monovalent free extracellular conditions to suppress other cationic conductance present in DRG neurons. The monovalent free solution contained 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM HEPES, 280 mM D-mannitol (pH 7.4 with N-methyl-Dglucamine). The holding potential for measurements in DRG neurons was 260 mV between voltage ramps. Voltage ramps were applied as described for measurements in HEK293 cells. Modulators were applied via a SF-77B Perfusion Fast Step system (Warner Instruments, Hamden, CT). Heat activation of TRPM3 was performed as described earlier (Straub et al., 2013 ) were applied from 295.4 mV to 1104.6 mV (liquid junction potential corrected by 24.6 mV) from a holding potential of 24.6 mV at a rate of 1 Hz with an EPC-10 amplifier controlled by the Patchmaster software (HEKA Instruments, Bellmore, NY). Pipettes were coated with paraffin and washed with water. Seal formation was achieved by approaching the oocyte and releasing the positive pipette pressure after cell contact. After a seal had been formed, a giant patch was excised by fast back-andforth movement of the pipette. The giant patch was placed in front of a custom application system with three channels. By moving the pipette, the patch was exposed to the constantly flowing solution stream of the different application channels.
MTT Viability Test. To measure a possible cytotoxicity of the flavonoids, enzymatic conversion of MTT [3-(4,5-dimethylthioazol-2-yl)-2,5-diphenyltetrazoliumbromid] was assessed. HEK293 cells were seeded onto a 96-well plate coated with poly-L-lysine (10,000 cells per well). The next day, the cells were incubated with the compounds diluted in cell culture medium for at least 24 hours. For colorimetric detection, the medium was exchanged to a phenol red-free medium (100 ml per well), containing 1.2 mM MTT, and the cells were placed in the incubator for 4 hours. Formazan complexes that arose were solubilized with DMSO, and absorbance was measured at 560 and 670 nm with the transmission spectrometer head of a plate reader device (POLARstar Omega). A solvent control was set as 100%, and measurements in presence of the indicated substances were normalized to this value.
Behavioral Analysis. All animal experiments were conducted in accordance with the accepted standards of animal care and were approved by the local authorities (regional governmental agency of the State of Saxony, Germany; TVV 02/12). We used 10-12-week-old female and male C57BL/6J mice. For the hot plate test, isosakuranetin (2 mg×kg 21 ) and hesperetin (10 mg×kg
21
) were dissolved in Miglyol 812 (Caesar & Loretz GmbH, Hilden, Germany) containing 0.1% DMSO, and compounds or the vehicle alone were injected intraperitoneally (6 ml×kg 21 ). Thirty minutes after the injection, mice were placed on a hot plate set to a temperature of 52°C. The delay to the first pain-related response (hindpaw shaking, lifting or licking, jumping) was measured by an investigator blind to substance application. Measurements of the body temperature were performed with a digital ear infrared thermometer (Thermoscan IRT 4520; Braun, Kronberg, Germany) in the mouse's armpit before and 30 minutes after injection of the compounds or vehicle.
The PregS-induced pain was assessed 30 minutes after i.p. injection of isosakuranetin (2 mg×kg
) and hesperetin (10 mg×kg 21 ) or vehicle. PregS was solved in distilled water. A volume of 10 ml containing 5 nmol of PregS was injected into the midplantar right hindpaw. The latency to, duration of, and number of nocifensive responses (paw licking, shaking, or lifting) were registered.
Plasma Concentrations. Plasma concentrations of isosakuranetin were determined with modifications according to (Vega-Villa et al., 2008) . Male and female mice were i.p. injected with 2 or 10 mg×kg 21 isosakuranetin, and whole blood samples were collected under anesthesia by heart puncture. Blood samples were centrifuged to obtain the plasma, and 200 ml of plasma were mixed with 25 ml of ethoxycoumarin (4 mM in acetonitrile) as internal standard and 600 ml of ice-cold acetonitrile. The plasma was stirred for 1 minute and centrifuged at 12,000g for 5 minutes. The supernatant was evaporated at 40°C under nitrogen, reconstituted in 100 ml of 30% acetonitrile containing 0.2% aqueous phosphoric acid (v/v), and centrifuged. Cleared supernatant (20 ml) was injected onto a highperformance liquid chromatography (HPLC) column (5 mm, 3 mm Â 150 mm; UltraSep ES PHARM RP18E; SepServ HPLC, Berlin, Germany) implemented in a HPLC system with absorbance detection at 288 nm (1100 series; Agilent Technologies, Böblingen, Germany). Separation was performed isocratically at 30°C with a mobile phase consisting of 44% acetonitril in 0.2% aqueous phosphoric acid (vol/vol) with a flow of 0.55 ml×min
. Stock Solutions and Drugs. All modulators were dissolved in DMSO, if not indicated otherwise. The concentration of stock solutions was chosen in such a way that the DMSO concentration in the final solution never exceeded 0.14% at the highest test concentration of the respective modulator and further reduced by serial dilution of the compounds. PregS, pinocembrin, 49-hydroxyflavanone, liquiritigenin, phloretin, formononetin, ononetin, and hesperetin were purchased from Sigma-Aldrich. Isosakuranetin was purchased from Carl Roth GmbH (Karlsruhe, Germany). 
Selective TRPM3 Inhibitors
Statistical Analysis. All data are expressed as mean 6 S.E.M. The number of cells analyzed in each experiment is indicated in the figure legends. To test for statistically significant differences, analysis of variance with the Tukey post hoc test was used. P , 0.05 was considered statistically significant. The pharmacochemical properties of isosakuranetin and liquiritigenin were obtained from www.chemicalize.org.
Results
Identification of Novel TRPM3-Blocking Flavanones. The three previously described TRPM3 blockers (Straub et al., 2013 )-naringenin, hesperetin, and eriodictyol-differ chemically only in the substitutions on the B ring of the flavanone structure (Fig. 1A) . These different substitutions account for differences in the potency to block TRPM3 and for the differences in the selectivity (Straub et al., 2013) . We now tested whether flavanones with different modifications at the A or C rings are still capable of blocking TRPM3 (Fig. 1) . HEK293 cells stably expressing TRPM3 (HEK mTRPM3 ) were incubated with the fluorescent calcium indicator dye Fluo-4, dispensed into 384-well plates that were prefilled with different concentrations of the flavonoids, and PregS (35 mM)-induced calcium entry was measured. Although weakly potent, 49-hydroxyflavanone, a flavanone that has no hydroxyl group on the A ring, was still a blocker (47% block at 25 mM) of TRPM3. Liquiritigenin, a flavanone that has a single hydroxyl group on the A ring (C7 atom), abrogated the PregSinduced [Ca 21 ] i signal when preincubated at a concentration of 25 mM. Pinocembrin differs from the potently TRPM3-blocking naringenin by a complete lack of hydroxyl groups on the B ring. It only partially inhibited the [Ca 21 ] i signal, highlighting the importance of these substitutions for a TRPM3 block. Conversely, isosakuranetin features a methoxy group at the C49 atom of the ring and completely blocked the PregSinduced [Ca 21 ] i entry into HEK mTRPM3 cells at a concentration of 25 mM.
Further, we were interested in whether the flavanone backbone is required to block TRPM3. To this end, we investigated several compounds from different flavonoid subgroups, including the flavonol quercetin, the flavone apigenin (Fig. 1B) , the flavanoles epicatechin and epigallocatechin (Fig. 1C) , the isoflavones genistein, daidzein, and formononetin (Fig. 1D) , and the dihydrochalcone phloretin (Fig. 1E) . Among the tested flavonoid subgroups, only phloretin partially blocked the PregS-induced calcium entry (Fig. 1B ) whereas none of the others exerted more than 20% inhibition of PregS-induced [Ca 21 ] i signals when applied at a concentration of 25 mM (see Fig. 1 ). We conclude that the flavanone backbone and substitutions at the A and B rings are required to strongly block TRPM3. Within the tested flavanones, isosakuranetin and liquiritigenin almost completely abrogated the PregS-induced elevations of [Ca 21 ] i in HEK mTRPM3 cells.
Concentration-Dependence of Liquiritigenin-and Isosakuranetin-Induced Block of TRPM3-Dependent Ca 21 Entry and Ionic Currents. To assess the potency of the newly identified blockers, we first performed fluorometric Ca 21 assays in HEK mTRPM3 cell suspensions that were exposed to serially diluted compounds and then stimulated with 35 mM PregS. Liquiritigenin elicited a half-maximal block with an IC 50 of 500 6 70 nM (Fig. 2, A and B) . Isosakuranetin blocked PregS-induced [Ca 21 ] i with an IC 50 of 50 6 6 nM (Fig. 2, C and D) . The Hill coefficients were 0.8 for liquiritigenin and 1.3 for isosakuranetin.
To characterize the impact of the more potently acting isosakuranetin on TRPM3 currents, we performed whole-cell patch-clamp measurements. To reassess the concentrationresponse curves with the more quantitative electrophysiologic method, PregS-induced currents were recorded in HEK mTRPM3 cells, and isosakuranetin was acutely added via the bath solution at various concentrations (Fig. 3) . The isosakuranetininduced TRPM3 block was slowly developing and recovering after removal of the modulator (Fig. 3A) . Isosakuranetin blocked the inward currents at 2113 mV slightly more potently (IC 50 5 80 6 13 nM) compared with the outward currents measured at 187 mV (IC 50 5 120 6 24 nM) (Fig. 3, B and C). The Hill coefficients were 1.0 for both liquiritigenin and isosakuranetin. Although the potency of TRPM3 block displayed some voltage dependence, both currents were isosakuranetin sensitive and almost completely blocked at a concentration of 3 mM (Fig. 3D) . Moreover, the currentvoltage relationship showed no prominent voltage dependence of the isosakuranetin-induced TRPM3 block (Fig. 3E) .
To test the biologic activity of the flavanones in the heatactivated mode of TRPM3, we performed whole-cell measurements with bath solutions heated to 37-40°C. Under these conditions, inward and outward currents in TRPM3-expressing cells were partially blocked by 3 mM of isosakuranetin (Fig. 4, A  and B) . Raising the temperature in measurements with nontransfected parental HEK293 cells also yielded small inward and outward currents that remained constant in the presence of 3 mM isosakuranetin (Fig. 4, C and D) . Thus, isosakuranetin presumably blocks the TRPM3-mediated component of heatinduced currents.
To assess the accessibility of the binding site and to exclude a requirement of cellular signaling cascades, we performed giant patch inside-out measurements on X. laevis oocytes that heterologously express TRPM3 (Fig. 5) . The pipette solution contained 50 mM PregS to activate TRPM3. The PregSinduced currents were strongly blocked by 1 or 10 mM isosakuranetin applied from the intracellular side (Fig. 5) . Because high intracellular concentrations of Mg 21 are known to inhibit TRPM3-induced currents (Oberwinkler et al., 2005) , the inside-out configuration of the patch was confirmed by applying 10 mM Mg 21 . Because 10 mM Mg 21 is expected to eliminate TRPM3 currents, the remaining inward and outward currents are likely to reflect TRPM3-unrelated leak currents that could not be subtracted because TRPM3-activating PregS in the pipette was present throughout the whole experiment. Notably, inhibition by 10 mM isosakuranetin was equally effective as the TRPM3 block by 10 mM Mg 21 . Because PregS binds to TRPM3 from the extracellular side (Wagner et al., 2008) , whereas isosakuranetin gets access to its binding side from the intracellular side of the membrane, a competitive mechanism is unlikely. From the inside-out patch experiments we also conclude that isosakuranetin blocks TRPM3 in a membrane-confined and presumably direct fashion.
Specificity of Flavanones to Modulate Sensory TRP Channels. To evaluate the specificity of the novel TRPM3 blockers, we first examined the impact of these flavanones on the most closely related TRPM1. TRPM1 can also be activated by PregS. Unlike TRPM3, TRPM1 is strongly blocked by extracellularly applied ZnCl 2 (Lambert et al., 2011) . When tested at a concentration of 10 mM, liquiritigenin had almost no inhibitory effect on TRPM1-mediated [Ca 21 ] i signals (Fig.  6A) . The more potent TRPM3 blocker isosakuranetin reduced PregS-induced [Ca 21 ] i responses by about 36% (Fig. 6B) . In Selective TRPM3 Inhibitors both experiments, ZnCl 2 (100 mM) was applied as a positive control for the TRPM1 block. TRPM3 is expressed in DRG neurons, and its activation is linked to thermosensation. We thus tested the ability of isosakuranetin and liquiritigenin to modulate other thermosensitive or sensory TRP channels, including transient receptor potential vanilloid-related (TRPV)1, TRPM8, and TRPA1. HEK293 cell lines stably expressing the respective TRP channel were loaded with Fluo-4/AM, preincubated with different concentrations of liquiritigenin or isosakuranetin, and agonist-induced increases in the Fluo-4 fluorescence were measured. Neither liquiritigenin nor isosakuranetin had an impact on the capsaicin (2 mM)-induced TRPV1 activation or the menthol (300 mM)-triggered activity of TRPM8 (Fig. 7, A  and B) .
The TRPA1 activation induced by allyl isothiocyanate (AITC) was, however, concentration dependently (2-50 mM) diminished by preincubation with either flavanone (Fig. 7,  A and B) . Because the irritant sensor TRPA1 is activated by many chemical compounds, we performed additional [Ca 21 ] i measurements with acutely added liquiritigenin and isosakuranetin and compared the effects to those elicited by the known TRPA1 activator AITC (30 mM). Indeed, liquiritigenin partially activated TRPA1 when acutely added at concentrations .20 mM (Fig. 7C) . Isosakuranetin also activated TRPA1 when added at concentrations .5 mM, and activation of TRPA1 by 50 mM isosakuranetin reached levels comparable to those elicited by AITC itself (Fig. 7D) .
To further evaluate the specificity of isosakuranetin and liquiritigenin among other members of the TRPM family, we investigated the blocking potency of the TRPM3-blocking compounds on endogenously expressed TRPM7 in HEK293 cells. TRPM7 is permanently blocked by divalent cations, but when patched with Mg 21 -free pipette solution, switching to a bath solution lacking Ca 21 and Mg 21 ions gives rise to large inward and outward currents (Nadler et al., 2001) . Because TRPM7-like currents exhibit a fast rundown when using a Na 1 -based bath solution, we used a Cs 1 -based bath solution, as described elsewhere (Chubanov et al., 2012) . Neither isosakuranetin nor liquiritigenin (20 mM each) affected TRPM7-dependent inward or outward currents in HEK293 cells (Fig. 8, A and B) .
Effects of TRPM3-Blocking Compounds on Cell Viability. Because we aimed at testing biologic effects of the TRPM3 blockers in vivo, we next assessed the cytotoxicity of the TRPM3-blocking substances in the parental HEK cell line by applying MTT tests. Within the tested compounds, liquiritigenin and ononetin did not significantly impair the cell proliferation and viability (Fig. 9 ). Hesperetin and isosakuranetin significantly reduced the MTT-converting enzymatic activity only partially and at the highest test concentration of 50 mM. Eriodictyol diminished the cell proliferation in concentrations of 50 and 25 mM, respectively. With an almost complete abrogation of the MTT conversion, naringenin was the most cytotoxic compound among the tested substances. All other flavanones were well tolerated by HEK cells at concentrations that would completely block the activation of TRPM3.
Effects of Flavanones on TRPM3 in Freshly Isolated Rat DRG Neurons. To test the biologic activity of novel TRPM3-blocking flavanones on endogenously expressed TRPM3, single-cell calcium measurements were performed using isolated rat DRG neurons that were loaded with the Ca 21 indicator dye Fura-2. Functional expression of TRPM3 has previously been described in small to medium diameter neurons (Vriens et al., 2011) . Therefore, all neurons that met this criterion were selected by defining regions of interest over single cells, and all cells that were sensitive to KCl were considered as neurones. About 60-70% of the neurons showed a PregS-induced calcium entry. A majority of but not all PregSpositive neurons were also sensitive to stimulation with capsaicin (Fig. 10, A and B) . The PregS-induced calcium entry was strongly counteracted either by 5 mM isosakuranetin (Fig. 10A) or by 10 mM liquiritigenin (Fig. 10B) . Because most PregS-sensitive DRG neurons also responded to stimulation with 2 mM capsaicin or to 50 mM KCl, we conclude that TRPM3 is expressed in a subpopulation of DRG neurons that also express voltage-gated Ca 21 channels and very often TRPV1.
Likewise, PregS-induced currents in rat DRG neurons were partially blocked upon addition of 1 mM isosakuranetin. Similar to heterologously expressed TRPM3, the isosakuranetininduced TRPM3 block was reversible (Fig. 10C) and showed a TRPM3-characteristic, outwardly rectifying current-voltage relationship (Fig. 10, D and E) . PregS-induced outward currents were concentration dependently blocked by isosakuranetin (Fig. 10F) , and the potency and efficacy of the block was comparable to that seen in HEK293 cells heterologously expressing TRPM3 (see Fig. 3B ).
Because isosakuranetin blocked TRPM3 in DRG neurons, we retested the selectivity of isosakuranetin on other sensory TRP channels within their native context. To this end, we investigated the effect of isosakuranetin (5 and 20 mM) on menthol-and capsaicin-induced increases in [Ca 21 ] i in freshly isolated DRG neurons (Fig. 11, A-D) . Isosakuranetin itself elicited a calcium entry in a small number of DRG neurons (Fig. 11 , B and C), whereas no obvious effect was observed on menthol-and capsaicin-sensitive DRG neurons (Fig. 11D) . Because overexpressed TRPA1 was partially activated by 20 mM isosakuranetin (Fig. 7D) , we performed measurements in NGF-treated, TRPA1-expressing DRG neurons (Fig. 11 , E-H). Again, 3 of 150 and 5 of 136 DRG neurons were activated by 5 and 20 mM isosakuranetin, respectively. Of note, all of them also responded to the subsequent stimulation with the TRPA1 activator AITC. AITC elicited increases in [Ca 21 ] i in 26-30% of NGF-treated DRG neurons. The previous exposure to isosakuranetin did not cause a decrease in AITCinduced [Ca 21 ] i responses in all DRG neurons nor in the AITC-sensitive subpopulation (Fig. 11H ). There was also no inhibition of KCl-induced [Ca 21 ] i signals in DRG neurons cultured either in the absence or in the presence of NGF.
Isosakuranetin and Hesperetin Attenuate the Sensitivity of Mice to Noxious Heat and PregS-Induced Pain Behavior. TRPM3 has previously been shown to be involved in the perception of noxious heat in vivo (Vriens et al., 2011) . We therefore investigated nocifensive responses in mice that were intraperitoneally injected with TRPM3-blocking flavanones 30 minutes before a hot plate assay.
Naringenin and hesperetin are citrus fruit flavanones that were often used for in vivo studies in mice and even in humans (Kanaze et al., 2007) . We therefore decided to perform the in vivo experiments with the newly identified and poorly described isosakuranetin and with hesperetin, which has already been published and tested in in vivo studies. We preferred hesperetin over naringenin because naringenin strongly impaired cell viability of HEK293 cells in concentrations up to 12.5 mM (Fig. 9) .
The latency of nocifensive behavior assessed on a hot plate (52°C) was significantly prolonged in mice after hesperetin (10 mg×kg 21 i.p.) or isosakuranetin (2 or 10 mg×kg 21 i.p.) treatment compared with vehicle-treated animals (Fig. 12A) . Note that 2 mg/kg hesperetin were not sufficient to significantly increase the pain latency. indicator Fura-2/AM. TRPM1 was activated with 50 mM PregS alone and in the presence of (A) 10 mM isosakuranetin (Iso; n = 55) or (B) 10 mM liquiritigenin (Liqu; n = 48), followed by application of PregS alone or in combination with 100 mM ZnCl 2 . Data shown are the mean 6 S.E.M. of 4-6 independent imaging experiments.
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Because antagonists of the thermosensitive TRPV1 elicited hyperthermia in different species such as rat and mouse (Gavva et al., 2008; Gunthorpe and Chizh, 2009 ), we measured the temperature of mice before and 30 minutes after injection of hesperetin and isosakuranetin. As shown in Fig. 12B , the newly identified TRPM3 blocker isosakuranetin or hesperetin attenuated the response to noxious heat in mice without altering their body temperature at either dosage.
The endogenous neurosteroid PregS acts as a chemical activator of TRPM3 (Wagner et al., 2008) and evokes pain (Ueda et al., 2001) . Intraplantar injection of PregS (2.5, 5.0, and 10.0 nmol) dose-dependently elicited prolonged nocifensive responses, consisting of vigorous licking and lifting of the hindpaw, whereas the injection of the vehicle did not cause a nocifensive behavior (data not shown). The duration and number of nocifensive events after blocking TRPM3 by isosakuranetin and hesperetin were measured at a PregS dose of 5 nmol per injected paw. Isosakuranetin at dosages of 2 and 10 mg×kg 21 significantly diminished the duration and the number of nocifensive movements (Fig.  12, C and D) . Hesperetin injected in the same doses did not significantly reduce nocifensive responses. No differences in the latency to the first response to PregS were observed (data not shown).
The antinociceptive effects of both isosakuranetin doses were similar and more pronounced than those observed by applying 10 mg×kg 21 hesperetin, indicating that isosakuranetin effects may be already saturated at a dose of 2 mg×kg 21 . Saturating effects may be caused by its higher potency but also by a lower percentage of conjugation. We therefore assessed the plasma concentrations that were achieved after Fig. 7 . Effects of liquiritigenin and isosakuranetin on other sensory TRP channels. HEK293 Fluo-4 loaded cells stably expressing the indicated TRP channels were dispensed into 384-well plates and preincubated with either liquiritigenin (A) or isosakuranetin (B). Activation of the respective channel was followed by measuring increases in the fluorescence intensity or in HEK rTRPV1:CFP cells by monitoring the Ca 2+ influx-mediated intracellular acidification, causing a decrease in the fluorescence intensity of coexpressed yellow fluorescent protein (Hellwig et al., 2004) . The respective activators are 2 mM capsaicin for TRPV1, 30 mM AITC for TRPA1, and 300 mM menthol for TRPM8. Acute stimulation of HEK293 cells stably expressing TRPA1 with liquiritigenin (C) and isosakuranetin (D) led to an activation of TRPA1. Data represent the mean 6 S.E.M. of 4-6 different experiments, performed in duplicate each. intraperitoneal application of 10 mg×kg 21 isosakuranetin. Peak concentrations were achieved about 10 minutes after the injection, but the individual variability was high (Fig. 12E) . A mean plasma concentration of 5.0 6 1.8 mg×ml 21 (17.5 6 6.3 mM) unconjugated isosakuranetin was measured 30 minutes after intraperitoneal application and with a lower individual Fig. 9 . Effect of TRPM3-blocking flavanones on cell viability. HEK293 cells were incubated with different concentrations of TRPM3-blocking flavanones, and cell viability was detected by performing a MTT viability test. Data represent the mean values 6 S.E.M. of 5-8 independent experiments. To test for statistically significant differences, analysis of variance with Tukey's post-hoc test was performed with the normalized data (*P , 0.05; **P , 0.01). variability. Plasma levels then dropped rapidly, presumably due to fast formation of metabolites. Thirty minutes after application of 2 mg×ml 21 , the mean plasma concentration of unconjugated isosakuranetin was 1.8 mM and may be sufficient to block TRPM3.
Discussion
Owing to their low potency and to their known actions on other biologic effectors, previously published TRPM3 blockers such as the peroxisome proliferator-activated receptor-gagonistic antidiabetic drug rosiglitazone (Majeed et al., 2011) Selective TRPM3 Inhibitors or the nonsteroidal anti-inflammatory drug mefenamic acid (IC 50 5 6.6 mM) (Klose et al., 2011) have not been used to investigate TRPM3 functions in vivo. Starting from the recent finding that citrus fruit flavanones block TRPM3, we sought to obtain nontoxic, selective, and potent TRPM3 inhibitors that may be used in animal models of pain perception. Hereby, the pharmacophore was confirmed, and substituent variation led to the identification of isosakuranetin and liquiritigenin as noncytotoxic, more potent, and selective TRPM3 inhibitors. Both recombinant TRPM3 and TRPM3-related [Ca 21 ] i signals and ionic currents in DRG neurons were strongly and reversibly inhibited. Other sensory TRP channels or TRPM1, the closest relative of TRPM3, remained largely unaffected at modulator concentrations that fully blocked TRPM3. In vivo application of isosakuranetin and hesperetin confirmed an antinociceptive effect on heat or PregS-induced pain responses. Interestingly, the intraperitoneal administration of both flavanones did not affect the body temperature, an effect that would be expected for compounds with TRPV1-antagonistic properties.
Besides a hit optimization strategy, we intended to more clearly assign the pharmacophore of flavonoid that is required to block TRPM3 and to assess the impact of the hydroxylation pattern at the A and C rings. In plants, flavonoids are usually present as glycosides. Upon enteral uptake, flavonoid glycosides are metabolized in a complex fashion. After consumption of naringin, the glycoside moiety is hydrolyzed by bacteria in the distal part of the intestine (Fuhr and Kummert, 1995) , and the corresponding aglycones are absorbed. In addition to phase I modification, flavanone aglycones undergo three types of phase II conjugation reactions: methylation, sulfation, and glucuronidation (Manach et al., 2004) . Accordingly, Silberberg et al. (2006) found plasma concentrations of 10-17 mM naringenin but also 100-120 nM of isosakuranetin and 230 nM hesperetin after feeding rats with a diet containing 0.5% naringin. Unlike naringenin, which is extensively metabolized to its glucuronide or sulfate conjugates, 52% of isosakuranetin and 94% of hesperetin remain unconjugated; therefore, they may exert biologic activities in vivo. Conjugated flavanone aglycones are typically eliminated, with half-times in the range of about 4 to 8 hours (Erlund et al., 2001) . To avoid possible uncertainties that may result from enteral resorption or hepatic first-pass elimination, we applied hesperetin or isosakuranetin by intraperitoneal injection.
Although the flavanone backbone appeared optimal for TRPM3 block, the hydroxylation pattern strongly impacted the potency to block TRPM3. The C79 hydroxylation at the A ring is favorable. The missing C59 hydroxylation at the A ring in liquiritigenin did not improve the potency to block TRPM3 compared with naringenin, but further increased the selectivity of the effect and lowered the cytotoxicity in HEK293 cells. Concerning the B ring, hydroxylation at the C39 atom appeared unfavorable, but 49-hydroxylation or 49-O-methylation improved the potency to block TRPM3 without strongly compromising the blocker selectivity. Thus, adding more complex substituents at the C49 position may provide a promising target for further investigation.
When compared with other biologic activities that have been reported for flavanones, inhibition of TRPM3 by various flavanones displays a distinct and unique preference. Liquiritigenin, a flavanone found in many plants including licorice, is a selective and potent estrogen receptor b (ER-b) agonist (EC 50 5 36.5 nM) (Mersereau et al., 2008) , which may relate to the beneficial effects observed after applying a liquiritigenin-containing herbal extract (MF101) used in traditional Chinese medicine to treat menopausal symptoms (Mersereau et al., 2008) . Isoflavones from soybeans, such as genistein and daizein, also act as phytoestrogens that bind to both ER-b and ER-a Mersereau et al., 2008) , but are poorly effective in blocking TRPM3.
Compared with our results with a higher potency of isosakuranetin to block TRPM3, the structure relationship for binding ER receptors differs from the structure needed to block TRPM3. Furthermore, glycosylation of naringenin, found in naringenin-6-C-glucoside or in naringin enhanced the estrogenic effect (Swarnkar et al., 2012) , whereas we previously demonstrated that glycosylation in naringin and hesperedin prevents the inhibition of TRPM3 (Straub et al., 2013) .
Besides their property to bind to ER receptors, flavonoids modulated phase I metabolizing enzymes via binding to proteins of the cytochrome P450 (P450) family. Naringenin and eriodictyol have been shown to block CYP1 activity, with an IC 50 . 4 mM. Naringenin also inhibits CYP3A4 and CYP19 (Moon et al., 2006) . With an IC 50 of 0.34 mM, liquiritigenin has been identified as a potent inhibitor of CYP19 (Paoletta et al., 2008) . Inhibitory effects of isosakuranetin on CYP1 enzyme isoforms require concentrations in the range of 1-3 mM (Takemura et al., 2010) , and inhibition of other P450 enzymes has, to our knowledge, not been demonstrated. We conclude that liquiritigenin may be the TRPM3 inhibitor with the highest selectivity compared with other TRP channels. Thus, when used as a cell biologic tool to profile TRP channel-related responses, liquiritigenin may be favorable. However, its effects on P450 enzymes and its ER-b-agonistic properties may interfere with its TRPM3-blocking properties in vivo. Isosakuranetin, by contrast, with respect to non-TRP channel off-target effects is a preferable compound for use in in vivo pharmacologic studies.
The physiologic and pathophysiologic functions of TRPM3 are still poorly understood. Different splice variants that impede on the Ca 21 permeability of the pore (e.g., the a1 splicing event) (Oberwinkler et al., 2005) or even eliminate a functional pore (Frühwald et al., 2012) further complicate the situation. In TRPM3-deficient transgenic mice, phenotypic alterations hint at a role of TRPM3 in thermal pain perception (Vriens et al., 2011) , an effect that is closely mimicked by a pharmacologic block of the channel, as described in the present study. Considering the expression of TRPV1 and TRPM3 in DRG neurons, the contribution of each of the heat-sensing sensory channels to thermal pain perception is intriguingly complex and seems redundant. However, pharmacologic inhibition of either TRPV1 or TRPM3 exerts similar antinociceptive effects. At present, a cross-talk between both channels has not been described. An efferent function of heat-sensitive, CGRP-releasing nociceptive neurons has been demonstrated in neurogenic inflammation, but may also contribute to the pyrexia-inducing effects of TRPV1 blockers. In contrast to TRPV1 blockers, the systemic administration of isosakuranetin did not cause a discernible increase in the body temperature. This observation hints to a promising feature of TRPM3 as a potential analgesic target molecule and may provide a strategy to avoid the adverse effects of TRPV1 blockers. The exact reason why a TRPM3 block is not associated with similar side effects than inhibitors of TRPV1 is not known. Possibly, the thermal threshold of TRPM3 activation is sufficiently high to avoid regulation by physiologic body or skin temperatures. Likewise, the marked shift of threshold temperatures described for TRPV1 in acidic or inflamed tissues (Gavva et al., 2008) may not apply to TRPM3. Finally, the population of DRG neurons that express TRPV1 or TRPM3 is not completely identical (Vriens et al., 2011) . Thus, TRPM3 activation may not exactly mimic TRPV1-induced responses.
Another open question relates to possible consequences of TRPM3 inhibition other than attenuation of thermal pain sensation. Obviously, we cannot exclude that such on-or offtarget effects may limit the therapeutic potential of TRPM3 inhibition. On the other hand, two lines of evidence support the assumption that TRPM3 inhibition may be tolerated: 1) the phenotype of TRPM3 2/2 mice is relatively mild, and 2) TRPM3-blocking compounds identified in this study are contained predominantly in citrus fruit that are part of our daily diet. In TRPM3 2/2 mice, a partially reduced pupillary response to light has been described (Hughes et al., 2012) . In contrast to a loss of TRPM1 that directly affects the function of bipolar cells in the retina, thereby causing congenital night blindness (Koike et al., 2010) , the effect of TRPM3 deficiency on pupillary responses is less pronounced (Hughes et al., 2012) . Future work will have to clarify whether acute inhibition of TRPM3 interferes with retinal functions. TRPM3 is functionally expressed in insulin-secreting beta cells. Although no obvious effects were observed in the resting blood glucose level in TRPM3
2/2 mice that exhibit no obvious developmental or metabolic deficits (Vriens et al., 2011) , the acute application of TRPM3 blockers may cause alterations of glucose homeostasis. Using the TRPM3-blocking flavanones, these questions may be addressed and help to clarify possible endocrine functions of TRPM3 in the pancreas.
As an off-target effect of flavanones, anti-inflammatory and/or antioxidant properties may add to effects on TRPM3 specifically, if pain regimes are being tested in models of inflammation. Such properties may thus overlap with the pain-alleviating effects of the TRPM3 inhibitors, such as in pain threshold tests with complete Freund's adjuvantinduced paw inflammation. Experimentally, the inhibition of carrageenan-induced paw edema formation by orally applied (50 mg×kg 21 day 21 ) or intravenously injected (15 mg×kg 21 day
21
) liquiritigenin has been demonstrated (Kim et al., 2008) . In a cell culture model using a lipopolysaccharideprimed macrophagelike cell line, Kim et al. (2008) observed an inhibition of cytokine production by 3-30 mM liquiritigenin. However, the TRPM3 block by liquiritigenin requires lower concentrations of the flavanone. In addition, systemically administered isosakuranetin was effective to elicit antinociceptive effects at a single dose of only 2 mg kg
. Thus, the highly potent and selective TRPM3 blockers described in this study may help disentangle the on-target and off-target effects that are related to the anti-inflammatory or antioxidant properties of flavanones. Within this context, a painalleviating effect of eriodictyol, another flavanone with antioxidant properties, has been described and attributed to TRPV1 inhibition (Rossato et al., 2011) . As outlined earlier, we were unable to reproduce inhibition of TRPV1, but demonstrated that eriodictyol efficiently blocks TRPM3. Interestingly, the eriodictyol-induced antinociceptive effect was not associated with hyperthermia. Likewise, the TRPM3-blocking compounds hesperetin and isosakuranetin did not increase the body temperature. Hence, flavanones with TRP channel-inhibiting properties and/or inhibition of TRPM3 may provide a promising starting point to develop novel and tolerable analgesic therapies.
